JB
VTVT icon

Julian Baker’s vTv Therapeutics VTVT Stock Holding History

Julian Baker’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.58M Hold
148,314
– – 0.03% 75
2026
Q1 		$5.88M Hold
148,314
– – 0.03% 73
2025
Q4 		$5.93M Hold
148,314
– – 0.03% 71
2025
Q3 		$3.46M Buy
148,314
+51,000
+52% +$895K 0.03% 75
2025
Q2 		$1.46M Hold
97,314
– – 0.01% 79
2025
Q1 		$1.69M Hold
97,314
– – 0.02% 78
2024
Q4 		$1.34M Hold
97,314
– – 0.01% 87
2024
Q3 		$1.32M Hold
97,314
– – 0.01% 83
2024
Q2 		$1.72M Hold
97,314
– – 0.02% 83
2024
Q1 		$2.29M Buy
+97,314
New +$1.24M 0.03% 72

Other funds holding VTVT

SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Julian Baker's VTVT Position: Q2 2026 in Review

Julian Baker held its vTv Therapeutics (VTVT) position steady in Q2 2026 at 148,314 shares worth $5.58M. The position accounts for 0.03% of the portfolio, ranked #75.

Julian Baker first reported a position in VTVT in Q1 2024 and has held it in 10 quarters since. The position peaked at $5.93M in Q4 2025. 45 funds tracked by Wall St. Rank hold VTVT as of Q2 2026.

  • Julian Baker held 148,314 shares of vTv Therapeutics worth $5.58M as of Q2 2026.
  • Julian Baker left its vTv Therapeutics share count unchanged in Q2 2026.
  • vTv Therapeutics made up 0.03% of Julian Baker's portfolio in Q2 2026, its #75 holding.
  • Julian Baker first reported a position in vTv Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • Julian Baker's vTv Therapeutics position peaked at $5.93M in Q4 2025.
  • 45 funds tracked by Wall St. Rank held vTv Therapeutics as of Q2 2026.

Based on Baker Bros. Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.